Beijing Pharma and Biotech Center

Dear  Sir/Madam: The Healthcare Industry Forum (26th-28th Oct., Beijing International Conventional Center, China) is forthcoming! Since 1997, 9 HIFs has been successfully held. On the occasion of the 10th anniversary of HIF, as the founder, also the organizer of HIF, BPBC would like to cordially invite all of HIF former speakers to be the honorable guests of 10th HIF. To extend our great appreciation of your ever supports and efforts for HIF, you will receive complementary registration for all 3 days (plenary session, roundtables, workshops, receptions, network functions and exclusive Speakers' Dinners), plus up 4 nights free accommodation during the forum. Attend the event to know the latest situations of China Pharma and biotech industry, to identify the emerging opportunities of China, to share successful developing experiences in China, to hear from and meet over 100 high level decision- and policy- makers both from overseas and local industry. Looking forward to meeting you in Beijing! Best regards, Ting Lei Director of Beijing Pharma and Biotech Center

Parts of Confirmed speakers: Wei Zhang, Director, Drug Registration Department, State Food and Drug Administration , SFDA Jiaqi Xu, Deputy Director, Department of Drug Safety & Inspection, SFDA Huiliang Bai, Director, China OTC Association Junzhi Wang, Deputy Director-General, NICPBP, SFDA He Huang, Vice General Director of Beijing Pharmaceutical Group Co.,Ltd, Director of Beijing Second Pharmaceutical Co., Ltd. Sverker Ljunghall, Vice President, Science Relations, Global Discovery, AstraZeneca Nahed Ahmed, Vice President, R&D, Amgen Inc Frank Douglas, Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology Patrick J Crowley, Vice President, Glaxo SmithKline Douglas A. Eayrs, President, MedVest Capital Paul M. Vanhoutte, Chairman of IUPHAR, Director of Biopharmaceutical Development Center of Hong Kong University ...... Visit www.hif.com.cn/en/ueren.asp to review the full current speaker list.

Topics to be discussed: China Opportunities during Industrial Globalization Activities & Gains--New Visage of Biopharmaceutical Industry Relations between Universities and Industry in Pharmaceutical Discovery Global R&D Division Adjustment and China Opportunity Opportunity & Challenge--Forecast of Pharmaceutical Industry What Preventive Measure Can a Chinese Pharmaceutical Company Take to Avoid a Losing Legal Battle in the US Brand Generic Drug Strategy, Opportunities for China Status and Strategy of Generic Drug Market Challenge and Bottleneck for China Enterprise Entering International Generic Market R&D Service, the Opportunity of Pharmaceutical Industry Differentiation Different Perspectives: Opportunity in Drug Non-Clinical Research Finding a Way for the Success of Biopharmaceutical R&D Service ...... Visit www.hif.com.cn/en/timetable.asp to review for the latest programme, including details of Plenary sessions, Roundtables, highly interactive workshops.

Beijing Pharma and Biotech Center (BPBC) Add: 151,MaLianWa North Road, Haidian District, 100094,Beijing, P.R.China Tel: 86-10-62896868 ext.807 Fax: 86-10-62899978 Website: www.newlife.org.cn Email: qiheng@newlife.org.cn

QI Heng International Affairs and Public Relations Department Beijing Pharma and Biotech Center(BPBC) Add: Institute of  Medicinal Plant Development, CAMS No. 151,MaLianWa North Road, Haidian District, 100094,Beijing,P.R.China Tel: 86-10-62896868 ext.807 Fax:86-10-62899978 E-mail: qiheng@newlife.org.cn